Royal Bank of Canada
STLN

Royal Bank of Canada’s Starling Oncology Institute, Inc. Common Stock STLN Stock Holding History

Royal Bank of Canada’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$68K Buy
22,257
+17,151
+336% +$52.6K ﹤0.01% 5338
2025
Q4 		$18K Buy
5,106
+3,568
+232% +$13.2K ﹤0.01% 6122
2025
Q3 		$5K Sell
1,538
-30,606
-95% -$105K ﹤0.01% 6715
2025
Q2 		$66K Buy
+32,144
New +$80.4K ﹤0.01% 5798
2024
Q3 		– Sell
-130
Closed – – 7441
2024
Q2 		$0 Buy
130
+75
+136% +$64 ﹤0.01% 7535
2024
Q1 		$0 Sell
55
-978
-95% -$1.86K ﹤0.01% 7594
2023
Q4 		$2K Sell
1,033
-6,837
-87% -$11.9K ﹤0.01% 6842
2023
Q3 		$11K Buy
7,870
+108
+1% +$112 ﹤0.01% 6398
2023
Q2 		$4K Buy
7,762
+5,753
+286% +$3.04K ﹤0.01% 6751
2023
Q1 		$1K Sell
2,009
-3,969
-66% -$5.06K ﹤0.01% 6938
2022
Q4 		$10K Buy
5,978
+5,376
+893% +$15.1K ﹤0.01% 6554
2022
Q3 		$3K Buy
602
+496
+468% +$2.92K ﹤0.01% 6928
2022
Q2 		$1K Sell
106
-473
-82% -$3.44K ﹤0.01% 7209
2022
Q1 		$4K Buy
+579
New +$3.91K ﹤0.01% 7339
2021
Q4 		– Sell
-2,580
Closed -$26K – 7894
2021
Q3 		$26K Buy
2,580
+80
+3% +$794 ﹤0.01% 6555
2021
Q2 		$25K Hold
2,500
– – ﹤0.01% 6452
2021
Q1 		$25K Buy
2,500
+2,200
+733% +$23.4K ﹤0.01% 6305
2020
Q4 		$3K Hold
300
– – ﹤0.01% 6810
2020
Q3 		$3K Hold
300
– – ﹤0.01% 6262
2020
Q2 		$3K Buy
+300
New +$2.98K ﹤0.01% 6214

Other funds holding STLN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KWM
Kanen Wealth Management Coconut Creek, Florida $278M AUM 38.85% 1-Year Est. Return
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.88% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royal Bank of Canada's STLN Position: Q1 2026 in Review

Royal Bank of Canada increased its Starling Oncology Institute, Inc. Common Stock (STLN) stake by 336% in Q1 2026, buying an estimated $52.6K and bringing the position to 22,257 shares worth $68K. The position accounts for ﹤0.01% of the portfolio, ranked #5338.

Royal Bank of Canada first reported a position in STLN in Q2 2020 and has held it in 20 quarters since. 115 funds tracked by Wall St. Rank hold STLN as of Q1 2026.

  • Royal Bank of Canada held 22,257 shares of Starling Oncology Institute, Inc. Common Stock worth $68K as of Q1 2026.
  • Royal Bank of Canada bought 17,151 Starling Oncology Institute, Inc. Common Stock shares in Q1 2026, an estimated $52.6K.
  • Starling Oncology Institute, Inc. Common Stock made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5338 holding.
  • Royal Bank of Canada first reported a position in Starling Oncology Institute, Inc. Common Stock in Q2 2020 and has held it in 20 quarters since.
  • 115 funds tracked by Wall St. Rank held Starling Oncology Institute, Inc. Common Stock as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.